EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Thiamidol: A Breakthrough Innovation in the Treatment of Hyperpigmentation

Cheri Frey, Pearl Grimes, Valerie D Callender, Andrew Alexis, Hilary Baldwin, Nada Elbuluk, Patricia Farris, Susan Taylor, Seemal R Desai

Journal of Drugs in Dermatology · 2025

DOI: 10.36849/jdd.9093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Cheri Frey und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hyperpigmentation, Monophenol Monooxygenase, Resorcinols. Die Arbeit wurde bisher 8-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperpigmentationMonophenol MonooxygenaseResorcinolsHumansNonprescription DrugsMelaninsTreatment OutcomeSkin PigmentationQuality of Life

Substanzen

Monophenol MonooxygenaseResorcinolsNonprescription DrugsMelanins

Zitieren

APA

Frey, C., Grimes, P., Callender, V. D., Alexis, A., Baldwin, H., Elbuluk, N., Farris, P., Taylor, S., & Desai, S. R. (2025). Thiamidol: A Breakthrough Innovation in the Treatment of Hyperpigmentation. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9093

Vancouver

Frey C, Grimes P, Callender VD, Alexis A, Baldwin H, Elbuluk N, et al. Thiamidol: A Breakthrough Innovation in the Treatment of Hyperpigmentation. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9093

BibTeX
@article{Frey2025,
  author = {Frey, Cheri and Grimes, Pearl and Callender, Valerie D and Alexis, Andrew and Baldwin, Hilary and Elbuluk, Nada and Farris, Patricia and Taylor, Susan and Desai, Seemal R},
  title = {Thiamidol: A Breakthrough Innovation in the Treatment of Hyperpigmentation},
  journal = {Journal of Drugs in Dermatology},
  year = {2025},
  doi = {10.36849/jdd.9093}
}
Kostenlos starten →